We have performed a comprehensive molecular characterization of unselected breast cancers and show a high rate of PTEN/PI3K pathway-related alterations in ER-negative breast cancer, an in particular show that basal-like breast cancers often display concomitant overexpression of EGFR and loss PTEN, the negative regulator of PI3K. This evidence concerns the gene PIK3CA and breast cancer.